Literature DB >> 3069115

Gene synthesis technology: recent developments and future prospects.

K L Beattie1, N J Logsdon, R S Anderson, J M Espinosa-Lara, R Maldonado-Rodriguez, J D Frost.   

Abstract

Gene synthesis is a potentially powerful tool in molecular biology that has not yet reached widespread use because of the relatively high cost and labor-intensive nature of the process. This paper reviews some recent technological developments and current research activities of this laboratory which promise to greatly reduce the cost of gene synthesis and to increase the speed and efficiency of the process. We recently developed an improved device for "segmented" synthesis of oligonucleotides, which utilizes porous Teflon wafers containing derivatized controlled pore glass supports to simultaneously synthesize up to 100 different DNA sequences. The stepwise coupling efficiency with the "wafer synthesis device" is as high as that attained with current automated "gene machines" producing 1-4 oligonucleotides at a time, whereas the reagent usage is only 20-50% that of the current DNA synthesizers. At present, we are optimizing the conditions for rapid, efficient assembly of genes on a solid-phase support, wherein ordered, stepwise annealing/washing is performed to segmentally elongate a "starting" oligonucleotide attached to a solid-phase support. We expect that the wafer synthesis device (operated at reduced scale of synthesis), together with solid-phase gene assembly, will permit the synthesis and assembly of an average size gene (1 kb) in one week at a cost of less than $1000. These developments should make gene synthesis a routine and powerful tool in molecular biology.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3069115

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  8 in total

1.  Mutation detection by stacking hybridization on genosensor arrays.

Authors:  R Maldonado-Rodriguez; M Espinosa-Lara; P Loyola-Abitia; W G Beattie; K L Beattie
Journal:  Mol Biotechnol       Date:  1999-02       Impact factor: 2.695

2.  A scalable high-throughput chemical synthesizer.

Authors:  Eric A Livesay; Ying-Horng Liu; Kevin J Luebke; Joel Irick; Yuri Belosludtsev; Simon Rayner; Robert Balog; Stephen Albert Johnston
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

3.  Hybridization of DNA targets to glass-tethered oligonucleotide probes.

Authors:  W G Beattie; L Meng; S L Turner; R S Varma; D D Dao; K L Beattie
Journal:  Mol Biotechnol       Date:  1995-12       Impact factor: 2.695

4.  Hybridization of glass-tethered oligonucleotide probes to target strands preannealed with labeled auxiliary oligonucleotides.

Authors:  R Maldonado-Rodriguez; M Espinosa-Lara; A Calixto-Suárez; W G Beattie; K L Beattie
Journal:  Mol Biotechnol       Date:  1999-02       Impact factor: 2.695

5.  A low density microarray method for the identification of human papillomavirus type 18 variants.

Authors:  Thuluz Meza-Menchaca; John Williams; Rocío B Rodríguez-Estrada; Aracely García-Bravo; Ángel Ramos-Ligonio; Aracely López-Monteon; Rossana C Zepeda
Journal:  Sensors (Basel)       Date:  2013-09-26       Impact factor: 3.576

6.  Resin capsules: permeable containers for parallel/combinatorial solid-phase organic synthesis.

Authors:  Isabelle Bouillon; Miroslav Soural; Viktor Krchnák
Journal:  J Comb Chem       Date:  2008-07-26

7.  Detection of mutations in RET proto-oncogene codon 634 through double tandem hybridization.

Authors:  Rogelio Maldonado-Rodríguez; Mercedes Espinosa-Lara; Oscar Barrera-León; Carmen Colin-Tovar; Beatriz González-Yebra; Mauricio Salcedo-Vargas; J Carlos Santiago-Hernández; Alfonso Méndez-Tenorio; Kenneth L Beattie
Journal:  Mol Biotechnol       Date:  2003-10       Impact factor: 2.695

8.  Recombinant PAL/PilE/FlaA DNA vaccine provides protective immunity against Legionella pneumophila in BALB/c mice.

Authors:  Yingying Chen; Zehui Yang; Ying Dong; Yu Chen
Journal:  BMC Biotechnol       Date:  2020-05-18       Impact factor: 2.563

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.